COMMENTARY: Asia's crude oil imports back to pre-war levels but refined fuels lag Reuters
Why MRM Stock dropped -3.24% Today — RQD Quant Desk Flash
MEDIROM Healthcare Technologies Inc. (MRM) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is MRM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $0.35 (-3.24% 1D, market cap $2.7M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1011 tracked Consumer Discretionary issuers, MRM ranks #528 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does MRM compare to OCG and PMAX in the Consumer Discretionary sector?
▼
Within the Consumer Discretionary sector (Other Consumer Services), MRM carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, OCG (Oriental Culture Holding LTD) holds a D+ grade (53/100 RQD, P/E N/A, ROIC -9.4%, cap $3.2M) and PMAX (Powell Max Limited (Class A)) posts a D+ grade (57/100 RQD, P/E N/A, ROIC —, cap $2.1M). Among the 5-stock peer group, MRM leads on earnings multiple (N/A) while OCG leads on capital efficiency (-9.4% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for MRM?
▼
For MEDIROM Healthcare Technologies Inc. (MRM), key quantitative strengths include Established market leader in Consumer Discretionary with deep daily trading liquidity. and sector rank #528 in Consumer Discretionary, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
SEC XBRL Trailing 12 Months: 0% FCF Margin ($76.6K FCF) & 52% Gross Margin
Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
⚔️ Adversarial Opposing Case: Why the MRM Bull Thesis Could Fail
Even with a 56/100 (D+) score, MRM faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Company executives have done more routine share selling than personal cash buying lately.
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($0.66) or 200D SMA ($1.05) invalidates the momentum regime and cuts Target Base ($0.35) toward Bear Floor ($0.27).
Why MRM Stock dropped -3.24% Today — RQD Quant Desk Flash
MEDIROM Healthcare Technologies Inc. (MRM) dropped -3.24% to $0.35, trading at 5% of its 52-week range ($0.25 – $2.33). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 5% of its 52-week range ($0.25 – $2.33) with RSI-14 at 23.1 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.35 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 52% gross margin and $76554 annual free cash flow.
Indian shares rise on Iran war talks, Reliance earnings beat Reuters
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Oil prices ease 3% on optimism for Qatari-led talks on ending Iran war Reuters
Nine people dead in Learjet crash in south Florida, officials say Reuters
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MRM)
- ✓Walkthrough of MRM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
MRM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on MRM today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for MRM. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MRM)
1. Head-to-Head Consumer Discretionary Peer Comparison (MRM vs. OCG, PMAX, EJH, JWEL)
Industry: Other Consumer Services (73 Tracked Issuers)Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, MEDIROM Healthcare Technologies Inc. (MRM) ranks #528 by composite RQD confidence (56/100, grade D+) and #988 by equity capitalization ($2.7M). Within this direct 5-issuer industry benchmark cohort, MRM leads on earnings valuation at N/A trailing P/E, while OCG leads on capital efficiency and profitability with -9.4% ROIC and 85.7% gross margin. PMAX currently holds the highest overall quantitative score in the immediate peer group at 57/100 (D+) compared with MRM at 56/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MRM
ACTIVE
MEDIROM Healthcare Technologies Inc. | D+ | 56/100 | — | — | — | -3.24% | $2.7M | Benchmark Subject |
| OCG Oriental Culture Holding LTD | D+ | 53/100 | — | 85.7% | -9.4% | +1.88% | $3.2M | /ocg-vs-mrm → |
| PMAX Powell Max Limited (Class A) | D+ | 57/100 | — | — | — | -0.31% | $2.1M | /pmax-vs-mrm → |
| EJH E-Home Household Service Holdings Limited | E | 33/100 | — | 22.4% | — | -3.65% | $4.2M | /ejh-vs-mrm → |
| JWEL Jowell Global Ltd. | D | 50/100 | — | — | -35.0% | +1.90% | $5.1M | /jwel-vs-mrm → |
2. MRM Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics
TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOTMEDIROM Healthcare Technologies Inc. (MRM) operates in Other Consumer Services (Consumer Discretionary) with an equity capitalization of $2.7M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
3. MRM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MRM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $0.35 (-3.24% 1D, market cap $2.7M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1011 tracked Consumer Discretionary issuers, MRM ranks #528 in composite RQD confidence.
How does MRM compare to OCG and PMAX in the Consumer Discretionary sector?
Within the Consumer Discretionary sector (Other Consumer Services), MRM carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, OCG (Oriental Culture Holding LTD) holds a D+ grade (53/100 RQD, P/E N/A, ROIC -9.4%, cap $3.2M) and PMAX (Powell Max Limited (Class A)) posts a D+ grade (57/100 RQD, P/E N/A, ROIC —, cap $2.1M). Among the 5-stock peer group, MRM leads on earnings multiple (N/A) while OCG leads on capital efficiency (-9.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MRM?
For MEDIROM Healthcare Technologies Inc. (MRM), key quantitative strengths include Established market leader in Consumer Discretionary with deep daily trading liquidity. and sector rank #528 in Consumer Discretionary, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MRM trading relative to its 50-day, 200-day, and 52-week technical levels?
MRM last traded at $0.35 (-3.24% on volume of 16,328 shares), positioning the stock -46.97% below its 50-day simple moving average ($0.66) and -66.67% below its 200-day simple moving average ($1.05). Across its 52-week range of $0.25 to $2.33, MRM sits at the 4.8% percentile with a 14-day RSI of 23.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.39).
MRM Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is MRM stock moving today?
Why MRM Stock dropped -3.24% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.